Dr. Karen M Schaaf, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2411 Pathways Xing, Belleville, IL 62221 Phone: 618-355-4778 Fax: 618-355-4415 |
Dr. Christine Elizabeth Petteway, AU.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 300 W Lincoln St, 102, Belleville, IL 62220 Phone: 618-234-2120 |
Mrs. Barbara G Yale, AUDIOLOGIST Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3601 N Belt W, Belleville, IL 62226 Phone: 618-235-8083 Fax: 618-641-4777 |
Auditory Consultations Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3601 North Belt West, Belleville, IL 62226 Phone: 618-235-8083 Fax: 618-641-4777 |
News Archive
Vanderbilt-led research, as part of an international, multicenter trial, found regular blood transfusion therapy significantly reduces the recurrence of silent strokes and strokes in children with sickle cell anemia who have had pre-existing silent strokes, according to study results released today in the New England Journal of Medicine (NEJM).
Horizon Pharma, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved RAYOS (prednisone) delayed-release tablets (1 mg, 2 mg and 5 mg) to treat a broad range of diseases including rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis (PsA), ankylosing spondylitis (AS), asthma and chronic obstructive pulmonary disease (COPD).
A new gastric balloon that can be swallowed like a pill and then filled while in the stomach, helped patients lose more than 37 percent of their excess weight over four months, according to new research presented here at ObesityWeek 2015, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The weeklong conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
In the first clinical trial of a medication that was used for an extended time to treat opioid addiction in young adults, participants who received counseling and Suboxone (buprenorphine-naloxone) for 12 weeks had substantially better outcomes than those who received the standard treatment of short-term detoxification and counseling.
› Verified 5 days ago